Search

everythinglearnresearchcommunity

for

Search:↓

Oral contraceptives can cause skin issues like dark patches, acne, yeast infections, sensitivity to light, spider veins, skin rashes, and hair loss.

Skin diseases are very common in poor areas, and there's a need for affordable ways to manage and improve skin health.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Common acne treatments can cause various side effects, like skin irritation and more serious issues, but combination therapies are often more effective and better tolerated.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

The document suggests medicine should integrate biological and cultural factors and focus on holistic, equitable care.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Platelet-Rich Plasma (PRP) shows promise for treating various skin conditions, but more research is needed to standardize its use.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

The document concludes that recognizing oral lesions is important for diagnosing syphilis.

Minoxidil and finasteride combo maintains hair density effectively.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.